AIM’s Upward Bound partnership serves first-generation/under-resourced college bound students from area schools, including ...

The antibodies attach to a part of the virus that doesn't appear to mutate, potentially allowing them to work on multiple ...

A big legal victory across the Atlantic Ocean was the news propelling Moderna (NASDAQ: MRNA) stock to a significant price ...

Candidate ceRNA relationship pairs were identified based on miRNA targeting relationships. Using the predicted miRNA-mRNA, lncRNA-miRNA, and circRNA-miRNA interaction pairs, groups of ...

The back-to-back high-level disruptions in vaccine policy under Robert F. Kennedy Jr. comes as the U.S. records its first ...

Earlier this week Ivy League scientists revealed key signs of an alarming new condition they believe is linked to mRNA Covid vaccines. The previously-unknown condition, dubbed post-vaccination ...

Moderna has established itself as a leader in mRNA-based therapeutics and vaccines, with its COVID-19 vaccine, SpikeVax, serving as the company’s primary revenue driver in recent years. However, the ...

We’ve put together this guide on how to pair your JLab earbuds and headphones, so you can skip the confusion and get straight to listening. Note: some models may show different colors to ...

Vaccines using messenger RNA, or mRNA, technology became widespread during the pandemic. With limited long-term studies available, the Trump administration is revisiting these vaccines. In response to ...

Dr. Vinod Balachandran says mRNA vaccines could stimulate the immune system to recognize and attack pancreatic cancer cells. An experimental approach to treating pancreatic cancer with the messenger ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 11.8% in the morning session after it continued to build on the 3% gain from Friday when it reported fourth-quarter 2024 financial results.